GSK’s share price has fallen this year due to growth concerns, but the issues facing the business should be temporary and growth may recover in 2021.

Navigating The Pandemic And Beyond

04:43am, Sunday, 02'nd Aug 2020
We still expect the economy to remain on a recovery path but it will not be as quick as earlier assumed.
GlaxoSmithKline (LON:GSK) had its target price reduced by research analysts at Goldman Sachs Group from GBX 2,060 ($25.35) to GBX 2,020 ($24.86) in a research report issued on Friday, Borsen Zeitung r
GlaxoSmithKline (LON:GSK) had its target price cut by analysts at DZ Bank from GBX 1,900 ($23.38) to GBX 1,850 ($22.77) in a report issued on Friday, Stock Target Advisor reports. The brokerage curren
Tempted by the GSK share price? Here’s what you need to know
French drug maker Sanofi and British pharmaceutical giant GlaxoSmithKline will be paid up to $2.1 billion to supply the United States with enough vaccines for 50 million people, the government announc
TWO major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine. British pharmaceutical giant GlaxoSmithKline and French drug maker Sanofi and…
DAVENPORT & Co LLC decreased its holdings in GlaxoSmithKline plc (NYSE:GSK) by 2.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
It's a very close competition.
The US government has selected a potential vaccine from Sanofi and GlaxoSmithKline for its Operation Warp Speed COVID-9 vaccine development initiative, committing up to $2.1 billion for an initial 100
"GSK en Belgique joue un rôle clé dans la lutte contre le Covid-19 car l'adjuvant qui sera utilisé dans le vaccin sera notamment produit sur le site de GSK à Wavre, qui est le plus grand site de p
The U.S. government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwrite the drugmakers' testing and manufacturing, the compani
The U.S. government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwrite the drugmakers' testing and manufacturing, the compani
Dr. Fauci talked vaccines in a televised House briefing while the U.S. entered into a $2.1 billion deal with Sanofi and GSK for a COVID-19 vaccine. Here's what you need to know.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE